The EPO published Abbott Diabetes Care's patent application EP4307314A1, covering systems and methods for analyzing glucose data including median values, variability metrics, and hypoglycemia risk assessment for therapy guidance. The patent names Timothy Christian Dunn and seven co-inventors, with designations covering 35 European states including Germany, France, UK, Italy, and Spain.

This is a routine patent publication with no compliance requirements. Medical device manufacturers and healthcare technology companies developing continuous glucose monitoring systems should monitor this intellectual property for competitive landscape awareness. No regulatory actions or filing deadlines apply to this patent publication.